Technical Principles and Advantages of a Fluorescent PCR-Capillary Electrophoresis Kit for Detecting the CYP2D6*10 Allele and Cardiovascular Drug Gene Polymorphisms

Detection System Design: Integration of Multiplex Fluorescent PCR and Capillary Electrophoresis

This kit targets five key gene loci—CYP2D6*10 (100C>T), CYP2C9*3 (1075A>C), ADRB1 (1165G>C), AGTR1 (1166A>C), and ACE I/D (insertion/deletion)—and employs fluorescent PCR-capillary electrophoresis for genotyping. Its core design involves simultaneous amplification of multiple target fragments in a single-tube reaction, using different fluorescent labels (such as FAM, HEX, ROX, etc.) to distinguish different loci or alleles. The amplification products are then separated by fragment size via capillary electrophoresis and detected by fluorescence signal, enabling synchronous analysis of multiple loci. This design eliminates the cumbersome steps of traditional single PCR followed by gel electrophoresis, improving detection throughput and efficiency.

Allele Identification and Interpretation Principles

For single nucleotide polymorphism (SNP) loci such as CYP2D6*10, CYP2C9*3, ADRB1 (1165G>C), and AGTR1 (1166A>C), the kit distinguishes alleles using allele-specific fluorescent probes or fragment length differences after primer extension followed by capillary electrophoresis. For example, for the CYP2D6*10 locus, two probes labeled with different fluorophores are designed to specifically bind wild-type and mutant templates, and the genotype is determined by the fluorescence signal ratio after PCR. For the ACE I/D polymorphism, discrimination is achieved directly through differences in amplified fragment length (the insertion-type fragment is longer, and the deletion-type fragment is shorter). The high resolution of capillary electrophoresis can clearly separate fragments differing by only a few bases, ensuring accurate genotyping.

Methodological Advantages: Sensitivity, Stability, and Automation Compatibility

The fluorescent PCR-capillary electrophoresis method combines the high sensitivity of PCR with the high resolving power of capillary electrophoresis. Compared with real-time quantitative PCR, this method is not affected by fluorescent dye interference and can simultaneously analyze multiple fragments of similar length; compared with traditional sequencing, it is simpler to perform and lower in cost, making it suitable for low- to medium-throughput clinical genetic testing. In addition, capillary electrophoresis instruments (such as the ABI 3500 series) are already widely deployed in clinical laboratories, and this kit can be seamlessly integrated into existing platforms to achieve a semi-automated workflow from nucleic acid extraction to data analysis. The kit also includes internal controls to monitor amplification efficiency and the electrophoresis process, avoiding false-negative or false-positive results.

Quality Control and Result Interpretation Specifications

When using this kit, positive quality control materials (DNA samples with known genotypes) and negative quality control materials (no-template controls) must be set up strictly according to the instructions. After electrophoresis, peak profiles are analyzed using the supporting software, and automated or manual interpretation is performed based on locus-specific fluorescence signals and fragment sizes. It should be noted that the CYP2D6 gene has highly homologous pseudogenes, and the kit design must avoid cross-amplification; for ACE I/D polymorphism interpretation, attention should be paid to the possible preferential amplification phenomenon in heterozygotes. Laboratories should establish standard operating procedures and combine the results with clinical drug metabolism information to provide a reference for medication adjustment.